识别乳腺癌相关淋巴的遗传倾向和临床风险因素:朝着个性化预防
Rizky Ifandriani Putri1,2, Noorwati Sutandyo2, Nurjati Chairani Siregar3
1Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Lymphatic research and biology
|February 17, 2026
概括
间隙结蛋白α-4 (GJA4) 和更高的体重指数 (BMI) 的遗传突变与手术后增加乳腺癌相关淋巴风险有关. 识别这些因素有助于为高风险患者制定有针对性的预防策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 淋巴 edem 研究 研究 淋巴 edem 研究
背景情况:
- 乳腺癌相关的淋巴 (BCRL) 是一个显著的慢性并发症后骨淋巴结解剖 (ALND).
- 遗传倾向在BCRL中的作用尚未得到充分研究,特别是在晚期乳腺癌病例中.
- 这项研究研究了遗传因素,特别是GJA4 rs705193突变,以及BCRL发展中的临床因素.
研究的目的:
- 确定与ALND.之后的BCRL发展相关的遗传和临床因素.
- 评估GJA4 rs705193突变作为BCRL风险的潜在生物标志物.
- 探索基因突变和临床因素对BCRL发病率的独立和联合影响.
主要方法:
- 一项针对106名接受ALND治疗的乳腺癌患者的前性队列研究.
- 在12个月的随访期间,通过绿色氨酸 (ICG) 淋巴学评估BCRL.
- 用桑格测序和多变量考克斯回归来评估风险因素的GJA4 rs705193突变的分析.
主要成果:
- 在随访期间,BCRL发生在52.8%的患者身上.
- 在BCRL患者中,体重指数 (BMI) 的升高显著高于BCRL患者 (27.3 vs 25.0 kg/m2).
- GJA4突变 (37.7%的患者) 和更高的BMI独立地与增加的BCRL风险相关 (HR=1.73和HR=1.75).
结论:
- GJA4 rs705193突变和升高的BMI是BCRL后ALND的独立风险因素.
- 这些发现支持为高风险乳腺癌患者制定个性化预防策略.
- 早期识别具有GJA4突变和高BMI的个体可以指导主动的淋巴 edem管理.
相关概念视频
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Development of the Lymphatic System
2.2K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.2K


